{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T13:05:38Z","timestamp":1780319138768,"version":"3.54.1"},"reference-count":129,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"NIH NCI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.canlet.2026.218504","type":"journal-article","created":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T17:34:56Z","timestamp":1776015296000},"page":"218504","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Nitroalkenes exploit dependence on autophagy-lysosome pathway in PARPi-Resistant triple negative breast cancer"],"prefix":"10.1016","volume":"651","author":[{"given":"Lisa","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanghoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Frisbie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2081-9433","authenticated-orcid":false,"given":"Yaoning","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Skoko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1987-5147","authenticated-orcid":false,"given":"Christopher","family":"Merkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsushi","family":"Kataura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor I.","family":"Korolchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3753-1652","authenticated-orcid":false,"given":"Lan G.","family":"Coffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian V.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce A.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J.","family":"Schopfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2801-9531","authenticated-orcid":false,"given":"Carola A.","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218504_bib1","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1158\/1078-0432.CCR-10-2560","article-title":"Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer","volume":"17","author":"Gonzalez-Angulo","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218504_bib2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.phrs.2005.02.010","article-title":"Chemopotentiation by PARP inhibitors in cancer therapy","volume":"52","author":"Tentori","year":"2005","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.canlet.2026.218504_bib3","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.annonc.2022.09.159","article-title":"Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1\/2 and high-risk, early breast cancer","volume":"33","author":"Geyer","year":"2022","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2026.218504_bib4","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1056\/NEJMoa2105215","article-title":"Adjuvant olaparib for patients with BRCA1- or BRCA2-Mutated breast cancer","volume":"384","author":"Tutt","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2026.218504_bib5","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJMoa1802905","article-title":"Talazoparib in patients with advanced breast cancer and a germline BRCA mutation","volume":"379","author":"Litton","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2026.218504_bib6","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/j.annonc.2020.08.2098","article-title":"Talazoparib versus chemotherapy in patients with germline BRCA1\/2-mutated HER2-negative advanced breast cancer: final overall survival results from the EMBRACA trial","volume":"31","author":"Litton","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2026.218504_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15143642","article-title":"Mechanisms of PARP-Inhibitor-Resistance in BRCA-mutated breast cancer and new therapeutic approaches","volume":"15","author":"Dilmac","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2026.218504_bib8","article-title":"PARP inhibitors: clinical limitations and recent attempts to overcome them","volume":"23","author":"Kim","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2026.218504_bib9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12943-020-01227-0","article-title":"PARP inhibitor resistance: the underlying mechanisms and clinical implications","volume":"19","author":"Li","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218504_bib10","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.tcb.2019.07.008","article-title":"PARP inhibitor resistance: a Tug-of-War in BRCA-mutated cells","volume":"29","author":"Noordermeer","year":"2019","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.canlet.2026.218504_bib11","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3892\/ijo.2015.3003","article-title":"The PARP inhibitor AZD2281 (Olaparib) induces autophagy\/mitophagy in BRCA1 and BRCA2 mutant breast cancer cells","volume":"47","author":"Arun","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2026.218504_bib12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13058-015-0534-y","article-title":"Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells","volume":"17","author":"Min","year":"2015","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.canlet.2026.218504_bib13","doi-asserted-by":"crossref","first-page":"14609","DOI":"10.1021\/acs.jmedchem.0c00873","article-title":"Design, synthesis, and characterization of an orally active dual-specific ULK1\/2 autophagy inhibitor that synergizes with the PARP inhibitor olaparib for the treatment of triple-negative breast cancer","volume":"63","author":"Ren","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.canlet.2026.218504_bib14","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/s41416-020-01238-0","article-title":"Targeting autophagy reverses de novo resistance in homologous recombination repair proficient breast cancers to PARP inhibition","volume":"124","author":"Pai Bellare","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2026.218504_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.908603","article-title":"Proteomic analysis identifies p62\/SQSTM1 as a critical player in PARP inhibitor resistance","volume":"12","author":"Uddin","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2026.218504_bib16","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/cncr.32600","article-title":"Poly(adenosine diphosphate ribose) polymerase inhibitors induce autophagy-mediated drug resistance in ovarian cancer cells, xenografts, and patient-derived xenograft models","volume":"126","author":"Santiago-O'Farrill","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2026.218504_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14163877","article-title":"Development of Olaparib-resistance prostate cancer cell lines to identify mechanisms associated with acquired resistance","volume":"14","author":"Cahuzac","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2026.218504_bib18","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41419-024-06984-0","article-title":"NLRP4 renders pancreatic cancer resistant to olaparib through promotion of the DNA damage response and ROS-Induced autophagy","volume":"15","author":"Xiao","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218504_bib19","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13568-019-0836-z","article-title":"Targeting autophagy potentiates the anti-tumor effect of PARP inhibitor in pediatric chronic myeloid leukemia","volume":"9","author":"Liu","year":"2019","journal-title":"AMB Express"},{"key":"10.1016\/j.canlet.2026.218504_bib20","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/carcin\/bgz104","article-title":"Targeting PARP and autophagy evoked synergistic lethality in hepatocellular carcinoma","volume":"41","author":"Zai","year":"2020","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.canlet.2026.218504_bib21","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1101\/gad.1599207","article-title":"Autophagy: process and function","volume":"21","author":"Mizushima","year":"2007","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2026.218504_bib22","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.semcdb.2010.03.002","article-title":"Physiological role of autophagy as an intracellular recycling system: with an emphasis on nutrient metabolism","volume":"21","author":"Kuma","year":"2010","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.canlet.2026.218504_bib23","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature06639","article-title":"Autophagy fights disease through cellular self-digestion","volume":"451","author":"Mizushima","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218504_bib24","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.semcdb.2010.03.009","article-title":"Regulation of macroautophagy in Saccharomyces cerevisiae","volume":"21","author":"Inoue","year":"2010","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.canlet.2026.218504_bib25","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.4161\/auto.25560","article-title":"The variability of autophagy and cell death susceptibility: unanswered questions","volume":"9","author":"Loos","year":"2013","journal-title":"Autophagy"},{"key":"10.1016\/j.canlet.2026.218504_bib26","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1126\/science.1193497","article-title":"Autophagy and metabolism","volume":"330","author":"Rabinowitz","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.canlet.2026.218504_bib27","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.tig.2008.10.002","article-title":"Autophagy and aging: keeping that old broom working","volume":"24","author":"Cuervo","year":"2008","journal-title":"Trends Genet."},{"key":"10.1016\/j.canlet.2026.218504_bib28","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nrm2245","article-title":"Autophagy: from phenomenology to molecular understanding in less than a decade","volume":"8","author":"Klionsky","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218504_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216307","article-title":"Autophagy and cancer drug resistance in dialogue: pre-Clinical and clinical evidence","volume":"570","author":"Qin","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218504_bib30","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1158\/1535-7163.MCT-11-0047","article-title":"The role of autophagy in cancer: therapeutic implications","volume":"10","author":"Yang","year":"2011","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.canlet.2026.218504_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106057","article-title":"Cardiac effects and toxicity of chloroquine: a short update","volume":"56","author":"Mubagwa","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.canlet.2026.218504_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e37098","article-title":"Chloroquine: rapidly withdrawing from first-line treatment of COVID-19","volume":"10","author":"Jia","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.canlet.2026.218504_bib33","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1074\/jbc.AC118.005899","article-title":"Electrophilic fatty acids impair RAD51 function and potentiate the effects of DNA-damaging agents on growth of triple-negative breast cells","volume":"294","author":"Asan","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2026.218504_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102856","article-title":"Small molecule nitroalkenes inhibit RAD51-mediated homologous recombination and amplify triple-negative breast cancer cell killing by DNA-Directed therapies","volume":"66","author":"Hong","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.canlet.2026.218504_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2024.115624","article-title":"Nitro fatty acids: a comprehensive review on analytical methods and levels in health and disease","volume":"694","author":"Elshoura","year":"2024","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.canlet.2026.218504_bib36","doi-asserted-by":"crossref","first-page":"31085","DOI":"10.1074\/jbc.M704085200","article-title":"Nitro-fatty acid reaction with glutathione and cysteine. Kinetic analysis of thiol alkylation by a michael addition reaction","volume":"282","author":"Baker","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2026.218504_bib37","doi-asserted-by":"crossref","first-page":"20450","DOI":"10.1074\/jbc.M602814200","article-title":"Reversible post-translational modification of proteins by nitrated fatty acids in vivo","volume":"281","author":"Batthyany","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2026.218504_bib38","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1038\/s41598-018-20460-8","article-title":"Electrophilic fatty acid nitroalkenes regulate Nrf2 and NF-\u03baB signaling:a medicinal chemistry investigation of structure-function relationships","volume":"8","author":"Khoo","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2026.218504_bib39","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.niox.2018.06.006","article-title":"Nitro-fatty acids: new drug candidates for chronic inflammatory and fibrotic diseases","volume":"79","author":"Schopfer","year":"2018","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.canlet.2026.218504_bib40","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1074\/jbc.M117.814368","article-title":"Nitro-fatty acid inhibition of triple-negative breast cancer cell viability, migration, invasion, and tumor growth","volume":"293","author":"Woodcock","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2026.218504_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14061420","article-title":"PARP inhibitors resistance: mechanisms and perspectives","volume":"14","author":"Giudice","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2026.218504_bib42","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13046-019-1490-7","article-title":"MiR-200c sensitizes Olaparib-resistant ovarian cancer cells by targeting Neuropilin 1","volume":"39","author":"Vescarelli","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218504_bib43","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00432-018-2774-6","article-title":"PARP inhibitors affect growth, survival and radiation susceptibility of human alveolar and embryonal rhabdomyosarcoma cell lines","volume":"145","author":"Camero","year":"2019","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218504_bib44","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1667\/RR15035.1","article-title":"Enhancement of soft tissue sarcoma cell radiosensitivity by Poly(ADP-ribose) Polymerase-1 inhibitors","volume":"190","author":"Mangoni","year":"2018","journal-title":"Radiat. Res."},{"key":"10.1016\/j.canlet.2026.218504_bib45","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13046-021-01930-w","article-title":"Efficacy and mechanism of the combination of PARP and CDK4\/6 inhibitors in the treatment of triple-negative breast cancer","volume":"40","author":"Zhu","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218504_bib46","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1126\/science.1204592","article-title":"TFEB links autophagy to lysosomal biogenesis","volume":"332","author":"Settembre","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.canlet.2026.218504_bib47","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/embor.2008.238","article-title":"PLIC proteins or ubiquilins regulate autophagy-dependent cell survival during nutrient starvation","volume":"10","author":"N'Diaye","year":"2009","journal-title":"EMBO Rep."},{"key":"10.1016\/j.canlet.2026.218504_bib48","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fonc.2014.00040","article-title":"In vitro development of chemotherapy and targeted therapy drug-resistant cancer cell lines: a practical guide with case studies","volume":"4","author":"McDermott","year":"2014","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2026.218504_bib49","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1158\/1535-7163.MCT-21-0604","article-title":"Olaparib-induced senescence is bypassed through G2-M checkpoint override in olaparib-resistant prostate cancer","volume":"21","author":"Lombard","year":"2022","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.canlet.2026.218504_bib50","first-page":"337","article-title":"Exploiting induced vulnerability to overcome PARPi resistance and clonal heterogeneity in BRCA mutant triple-negative inflammatory breast cancer","volume":"12","author":"Shih","year":"2022","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218504_bib51","doi-asserted-by":"crossref","DOI":"10.1126\/science.adj7446","article-title":"A p62-dependent rheostat dictates micronuclei catastrophe and chromosome rearrangements","volume":"385","author":"Martin","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.canlet.2026.218504_bib52","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/s41467-017-02746-z","article-title":"Oxidation of SQSTM1\/p62 mediates the link between redox state and protein homeostasis","volume":"9","author":"Carroll","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218504_bib53","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41467-017-00085-7","article-title":"p62\/SQSTM1\/Sequestosome-1 is an N-recognin of the N-end rule pathway which modulates autophagosome biogenesis","volume":"8","author":"Cha-Molstad","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218504_bib54","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1016\/j.molcel.2023.09.004","article-title":"S-acylation of p62 promotes p62 droplet recruitment into autophagosomes in Mammalian autophagy","volume":"83","author":"Huang","year":"2023","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2026.218504_bib55","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1038\/s41467-018-05825-x","article-title":"Insights into degradation mechanism of N-end rule substrates by p62\/SQSTM1 autophagy adapter","volume":"9","author":"Kwon","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218504_bib56","first-page":"729","article-title":"Oligomer model of PB1 domain of p62\/SQSTM1 based on crystal structure of homo-dimer and calculation of helical characteristics","volume":"42","author":"Lim","year":"2019","journal-title":"Mol. Cells"},{"key":"10.1016\/j.canlet.2026.218504_bib57","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1523\/JNEUROSCI.1508-21.2022","article-title":"S-Nitrosylation of p62 inhibits autophagic flux to promote \u03b1-Synuclein secretion and spread in Parkinson's Disease and lewy body dementia","volume":"42","author":"Oh","year":"2022","journal-title":"J. Neurosci."},{"key":"10.1016\/j.canlet.2026.218504_bib58","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ade0764","article-title":"Mechanistic insight into female predominance in Alzheimer's disease based on aberrant protein S-nitrosylation of C3","volume":"8","author":"Yang","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.canlet.2026.218504_bib59","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1016\/j.jmb.2020.01.020","article-title":"The pROS of autophagy in neuronal health","volume":"432","author":"Sedlackova","year":"2020","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.canlet.2026.218504_bib60","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1016\/j.devcel.2024.04.020","article-title":"Suppressed basal mitophagy drives cellular aging phenotypes that can be reversed by a p62-targeting small molecule","volume":"59","author":"Kelly","year":"2024","journal-title":"Dev. Cell"},{"key":"10.1016\/j.canlet.2026.218504_bib61","doi-asserted-by":"crossref","first-page":"15046","DOI":"10.1021\/ja044996f","article-title":"A strain-promoted [3 + 2] azide-alkyne cycloaddition for covalent modification of biomolecules in living systems","volume":"126","author":"Agard","year":"2004","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.canlet.2026.218504_bib62","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1021\/jo011148j","article-title":"Peptidotriazoles on solid phase: [1,2,3]-triazoles by regiospecific copper(i)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides","volume":"67","author":"Torn\u00f8e","year":"2002","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.canlet.2026.218504_bib63","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1002\/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4","article-title":"A stepwise huisgen cycloaddition process: copper(i)-catalyzed regioselective \"ligation\" of azides and terminal alkynes","volume":"41","author":"Rostovtsev","year":"2002","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.canlet.2026.218504_bib64","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/9780470559277.ch110148","article-title":"Copper-catalyzed azide-alkyne click chemistry for bioconjugation","volume":"3","author":"Presolski","year":"2011","journal-title":"Curr Protoc Chem Biol"},{"key":"10.1016\/j.canlet.2026.218504_bib65","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1021\/tx700347w","article-title":"Identification of protein targets of 4-hydroxynonenal using click chemistry for ex vivo biotinylation of azido and alkynyl derivatives","volume":"21","author":"Vila","year":"2008","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.canlet.2026.218504_bib66","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1021\/pr5002862","article-title":"Direct detection of biotinylated proteins by mass spectrometry","volume":"13","author":"Schiapparelli","year":"2014","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.canlet.2026.218504_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102126","article-title":"Chemoproteomic profiling reveals cellular targets of nitro-fatty acids","volume":"46","author":"Fang","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.canlet.2026.218504_bib68","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1111\/febs.13540","article-title":"p62\/SQSTM1 functions as a signaling hub and an autophagy adaptor","volume":"282","author":"Katsuragi","year":"2015","journal-title":"FEBS J."},{"key":"10.1016\/j.canlet.2026.218504_bib69","doi-asserted-by":"crossref","first-page":"D33","DOI":"10.1093\/nar\/gkad1044","article-title":"Database resources of the National Center for biotechnology information","volume":"52","author":"Sayers","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2026.218504_bib70","doi-asserted-by":"crossref","first-page":"6927","DOI":"10.1111\/febs.15672","article-title":"Structure and function of p62\/SQSTM1 in the emerging framework of phase separation","volume":"288","author":"Berkamp","year":"2021","journal-title":"FEBS J."},{"key":"10.1016\/j.canlet.2026.218504_bib71","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/ncb2788","article-title":"Emerging regulation and functions of autophagy","volume":"15","author":"Boya","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218504_bib72","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.drup.2015.11.004","article-title":"Lysosomes as mediators of drug resistance in cancer","volume":"24","author":"Zhitomirsky","year":"2016","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.canlet.2026.218504_bib73","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb2210","article-title":"Increased lysosomal biomass is responsible for the resistance of triple-negative breast cancers to CDK4\/6 inhibition","volume":"6","author":"Fassl","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.canlet.2026.218504_bib74","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1200\/JCO.2007.14.4147","article-title":"Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer","volume":"26","author":"Liedtke","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218504_bib75","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1038\/bjc.2013.144","article-title":"Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriers","volume":"108","author":"Lips","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2026.218504_bib76","first-page":"1071","article-title":"The epidemiology of triple-negative breast cancer, including race","volume":"20","author":"Trivers","year":"2009","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.canlet.2026.218504_bib77","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.dnarep.2018.08.021","article-title":"Mechanisms of PARP inhibitor sensitivity and resistance","volume":"71","author":"D'Andrea","year":"2018","journal-title":"DNA Repair"},{"key":"10.1016\/j.canlet.2026.218504_bib78","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s42003-022-03210-5","article-title":"Pre-activation of autophagy impacts response to olaparib in prostate cancer cells","volume":"5","author":"Cahuzac","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.canlet.2026.218504_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217285","article-title":"Autophagy and cancer therapy","volume":"605","author":"Pimentel","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218504_bib80","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.3389\/fonc.2020.01156","article-title":"Targeting lysosomes in cancer as promising strategy to overcome Chemoresistance-A mini review","volume":"10","author":"Geisslinger","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2026.218504_bib81","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/s41573-019-0036-1","article-title":"Lysosomes as a therapeutic target","volume":"18","author":"Bonam","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.canlet.2026.218504_bib82","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41392-021-00778-y","article-title":"Targeting lysosomes in human disease: from basic research to clinical applications","volume":"6","author":"Cao","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218504_bib83","doi-asserted-by":"crossref","first-page":"6150","DOI":"10.1038\/s41467-024-50500-z","article-title":"The AKT2\/SIRT5\/TFEB pathway as a potential therapeutic target in non-neovascular AMD","volume":"15","author":"Ghosh","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218504_bib84","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1080\/15548627.2016.1179404","article-title":"A novel curcumin analog binds to and activates TFEB in vitro and in vivo independent of MTOR inhibition","volume":"12","author":"Song","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.canlet.2026.218504_bib85","doi-asserted-by":"crossref","first-page":"14786","DOI":"10.1074\/jbc.M117.786160","article-title":"Adaptor protein p62 promotes skin tumor growth and metastasis and is induced by UVA radiation","volume":"292","author":"Sample","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2026.218504_bib86","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021109997","article-title":"Feeding activates FGF15\u2010SHP\u2010TFEB\u2010mediated lipophagy in the gut","volume":"41","author":"Seok","year":"2022","journal-title":"EMBO J."},{"key":"10.1016\/j.canlet.2026.218504_bib87","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.7150\/ijbs.91480","article-title":"Impaired TFEB-Mediated autophagy-lysosome fusion promotes tubular cell cycle G2\/M arrest and renal fibrosis by suppressing ATP6V0C expression and interacting with SNAREs","volume":"20","author":"Ren","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.canlet.2026.218504_bib88","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8099459","article-title":"Melatonin ameliorates the progression of alzheimer's disease by inducing TFEB nuclear translocation, promoting mitophagy, and regulating NLRP3 inflammasome activity","volume":"2022","author":"Fan","year":"2022","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.canlet.2026.218504_bib89","doi-asserted-by":"crossref","first-page":"71635","DOI":"10.18632\/oncotarget.11928","article-title":"Novel role of miR-29a in pancreatic cancer autophagy and its therapeutic potential","volume":"7","author":"Kwon","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2026.218504_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101189","article-title":"TFEB insufficiency promotes cardiac hypertrophy by blocking autophagic degradation of GATA4","volume":"297","author":"Song","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2026.218504_bib91","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40104-021-00561-7","article-title":"Transcription factor EB (TFEB)-Mediated autophagy protects bovine mammary epithelial cells against H2O2-induced oxidative damage in vitro","volume":"12","author":"Sun","year":"2021","journal-title":"J. Anim. Sci. Biotechnol."},{"key":"10.1016\/j.canlet.2026.218504_bib92","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1080\/15548627.2019.1704104","article-title":"Oxidation of multiple MiT\/TFE transcription factors links oxidative stress to transcriptional control of autophagy and lysosome biogenesis","volume":"16","author":"Wang","year":"2020","journal-title":"Autophagy"},{"key":"10.1016\/j.canlet.2026.218504_bib93","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41467-017-02352-z","article-title":"Oxidation of Atg3 and Atg7 mediates inhibition of autophagy","volume":"9","author":"Frudd","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218504_bib94","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1038\/sj.emboj.7601623","article-title":"Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4","volume":"26","author":"Scherz-Shouval","year":"2007","journal-title":"EMBO J."},{"key":"10.1016\/j.canlet.2026.218504_bib95","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1016\/j.cell.2024.03.027","article-title":"DrugMap: a quantitative pan-cancer analysis of cysteine ligandability","volume":"187","author":"Takahashi","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218504_bib96","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1016\/j.cell.2023.04.026","article-title":"Systematic identification of anticancer drug targets reveals a nucleus-to-mitochondria ROS-Sensing pathway","volume":"186","author":"Zhang","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218504_bib97","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1158\/2767-9764.CRC-24-0339","article-title":"PINK1-Mediated mitochondrial activity confers olaparib resistance in prostate cancer cells","volume":"4","author":"Schaaf","year":"2024","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.canlet.2026.218504_bib98","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.3390\/cancers15215273","article-title":"Therapeutic resistance models and treatment sequencing in advanced prostate cancer","volume":"15","author":"Schaaf","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2026.218504_bib99","article-title":"Targeting polyploid giant cancer cells potentiates a therapeutic response and overcomes resistance to PARP inhibitors in ovarian cancer","volume":"9","author":"Zhang","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.canlet.2026.218504_bib100","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41523-022-00427-9","article-title":"Identification of biomarkers of response to preoperative talazoparib monotherapy in treatment na\u00efve gBRCA+ breast cancers","volume":"8","author":"Liu","year":"2022","journal-title":"npj Breast Cancer"},{"key":"10.1016\/j.canlet.2026.218504_bib101","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41698-021-00232-w","article-title":"Multiomics analysis of serial PARP inhibitor treated metastatic TNBC inform on rational combination therapies","volume":"5","author":"Labrie","year":"2021","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.canlet.2026.218504_bib102","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s41419-024-06894-1","article-title":"Onvansertib treatment overcomes olaparib resistance in high-grade ovarian carcinomas","volume":"15","author":"Chiappa","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218504_bib103","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1158\/0008-5472.CAN-20-2912","article-title":"Heterogeneity and clonal evolution of acquired PARP inhibitor resistance in TP53- and BRCA1-Deficient cells","volume":"81","author":"F\u00e4rkkil\u00e4","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218504_bib104","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.tcb.2016.11.011","article-title":"Repair, reuse, recycle: the expanding role of autophagy in genome maintenance","volume":"27","author":"Hewitt","year":"2017","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.canlet.2026.218504_bib105","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18112351","article-title":"Autophagy roles in the modulation of DNA repair pathways","volume":"18","author":"Gomes","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2026.218504_bib106","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1080\/15548627.2016.1210368","article-title":"SQSTM1\/p62 mediates crosstalk between autophagy and the UPS in DNA repair","volume":"12","author":"Hewitt","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.canlet.2026.218504_bib107","doi-asserted-by":"crossref","first-page":"5941","DOI":"10.1074\/jbc.M109.039925","article-title":"Nucleocytoplasmic shuttling of p62\/SQSTM1 and its role in recruitment of nuclear polyubiquitinated proteins to promyelocytic leukemia bodies","volume":"285","author":"Pankiv","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2026.218504_bib108","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1007\/s12311-011-0281-2","article-title":"Distribution and pattern of pathology in subjects with familial or sporadic late-onset cerebellar ataxia as assessed by p62\/sequestosome immunohistochemistry","volume":"10","author":"Pikkarainen","year":"2011","journal-title":"Cerebellum"},{"key":"10.1016\/j.canlet.2026.218504_bib109","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1172\/JCI73941","article-title":"The role for autophagy in cancer","volume":"125","author":"White","year":"2015","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2026.218504_bib110","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.cell.2011.10.026","article-title":"Autophagy: renovation of cells and tissues","volume":"147","author":"Mizushima","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218504_bib111","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.jmb.2016.02.004","article-title":"Mechanisms of selective autophagy","volume":"428","author":"Zaffagnini","year":"2016","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.canlet.2026.218504_bib112","doi-asserted-by":"crossref","first-page":"42464","DOI":"10.1074\/jbc.M504212200","article-title":"Fatty acid transduction of nitric oxide signaling: multiple nitrated unsaturated fatty acid derivatives exist in human blood and urine and serve as endogenous peroxisome proliferator-activated receptor ligands","volume":"280","author":"Baker","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2026.218504_bib113","doi-asserted-by":"crossref","first-page":"35686","DOI":"10.1074\/jbc.M603357200","article-title":"Nitrated fatty acids: endogenous anti-inflammatory signaling mediators","volume":"281","author":"Cui","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2026.218504_bib114","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.freeradbiomed.2012.11.015","article-title":"Nitrated fatty acids: synthesis and measurement","volume":"59","author":"Woodcock","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.canlet.2026.218504_bib115","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1021\/ol0613463","article-title":"Synthesis of nitrolipids. All four possible diastereomers of nitrooleic acids: (E)- and (Z)-, 9- and 10-nitro-octadec-9-enoic acids","volume":"8","author":"Woodcock","year":"2006","journal-title":"Org. Lett."},{"key":"10.1016\/j.canlet.2026.218504_bib116","doi-asserted-by":"crossref","first-page":"W739","DOI":"10.1093\/nar\/gkac382","article-title":"SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples","volume":"50","author":"Ianevski","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2026.218504_bib117","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.molcel.2020.06.026","article-title":"RAD51AP1 is an essential mediator of alternative lengthening of telomeres","volume":"79","author":"Barroso-Gonzalez","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2026.218504_bib118","doi-asserted-by":"crossref","first-page":"614","DOI":"10.4161\/auto.6.5.12189","article-title":"Keap1 facilitates p62-mediated ubiquitin aggregate clearance via autophagy","volume":"6","author":"Fan","year":"2010","journal-title":"Autophagy"},{"key":"10.1016\/j.canlet.2026.218504_bib119","doi-asserted-by":"crossref","DOI":"10.3791\/1849","article-title":"Mammary epithelial transplant procedure","author":"Dunphy","year":"2010","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.canlet.2026.218504_bib120","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.3317","article-title":"HISAT: a fast spliced aligner with low memory requirements","volume":"12","author":"Kim","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.canlet.2026.218504_bib121","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.canlet.2026.218504_bib122","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-Seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.canlet.2026.218504_bib123","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data","volume":"32","author":"Gu","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.canlet.2026.218504_bib124","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1471-2105-12-35","article-title":"VennDiagram: a package for the generation of highly-customizable Venn and Euler diagrams in R","volume":"12","author":"Chen","year":"2011","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.canlet.2026.218504_bib125","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2026.218504_bib126","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btad325","article-title":"IndepthPathway: an integrated tool for in-depth pathway enrichment analysis based on single-cell sequencing data","volume":"39","author":"Lee","year":"2023","journal-title":"Bioinformatics"},{"key":"10.1016\/j.canlet.2026.218504_bib127","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","article-title":"Molecular signatures database (MSigDB) 3.0","volume":"27","author":"Liberzon","year":"2011","journal-title":"Bioinformatics"},{"key":"10.1016\/j.canlet.2026.218504_bib128","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/wics.147","article-title":"ggplot2","volume":"3","author":"Wickham","year":"2011","journal-title":"WIREs Computational Statistics"},{"key":"10.1016\/j.canlet.2026.218504_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114551","article-title":"Carcinoma-associated mesenchymal stem cells promote ovarian cancer heterogeneity and metastasis through mitochondrial transfer","volume":"43","author":"Frisbie","year":"2024","journal-title":"Cell Rep."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526002673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526002673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T12:08:31Z","timestamp":1780315711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526002673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":129,"alternative-id":["S0304383526002673"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218504","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nitroalkenes exploit dependence on autophagy-lysosome pathway in PARPi-Resistant triple negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218504","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"218504"}}